-transparent.png){kind=logo}
The uptake of Tc-99m tetrofosmin (TF) is reported in a case of parathyroid adenoma. A 65-year-old woman was studied on different days with TF, Tc-99m sestamibi (MIBI) and Tl-201 chloride (Tl). TF and MIBI injections were preceded by oral administration of potassium perchlorate. Clear identification of the adenoma was observed in all scans. No further information was obtained using a subtraction technique with Tc-99m pertechnetate. Regarding the thyroid/parathyroid ratio, different kinetics between TF and MIBI appear to be demonstrated. In particular, thyroid washout was observed with MIBI but not with TF.
Related Publications
L Mansi, and
P F Rambaldi, and
G Marino, and
B Pecori, and
E Del Vecchio
October 2007,
Arquivos brasileiros de endocrinologia e metabologia,
L Mansi, and
P F Rambaldi, and
G Marino, and
B Pecori, and
E Del Vecchio
January 1999,
Nuklearmedizin. Nuclear medicine,
L Mansi, and
P F Rambaldi, and
G Marino, and
B Pecori, and
E Del Vecchio
December 1997,
Clinical nuclear medicine,
L Mansi, and
P F Rambaldi, and
G Marino, and
B Pecori, and
E Del Vecchio
November 1996,
Clinical nuclear medicine,
L Mansi, and
P F Rambaldi, and
G Marino, and
B Pecori, and
E Del Vecchio
December 1999,
Clinical nuclear medicine,
L Mansi, and
P F Rambaldi, and
G Marino, and
B Pecori, and
E Del Vecchio
January 2000,
Clinical nuclear medicine,
L Mansi, and
P F Rambaldi, and
G Marino, and
B Pecori, and
E Del Vecchio
January 1997,
Acta medica Austriaca,
L Mansi, and
P F Rambaldi, and
G Marino, and
B Pecori, and
E Del Vecchio
April 2006,
Clinical nuclear medicine,
L Mansi, and
P F Rambaldi, and
G Marino, and
B Pecori, and
E Del Vecchio
April 1998,
Clinical nuclear medicine,
L Mansi, and
P F Rambaldi, and
G Marino, and
B Pecori, and
E Del Vecchio
January 2001,
Clinical nuclear medicine,
